Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 2, 2011, Pages 183-192

  Shah, Shefaat Ullah ^a   Shah, Kifayat Ullah ^a   Rehman, Asimur ^a   Khan, Gul Majid ^a  

^a GOMAL UNIVERSITY   (Pakistan)

Author keywords

Controlled release tablets; Diclofenac Potassium; Ethocel Standard FP Premium; Ethocel Standard Premium; Influence of co excipients; Release pattern and kinetics

Indexed keywords

DICLOFENAC POTASSIUM; ETHYL CELLULOSE; EXCIPIENT; PHOSPHATE;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISSOLUTION; DRUG DETERMINATION; IN VITRO STUDY; KINETICS; TABLET COMPRESSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBOXYMETHYLCELLULOSE SODIUM; CELLULOSE; DICLOFENAC; EXCIPIENTS; METHYLCELLULOSE; SOLUBILITY; TABLETS;

EID: 79953897650     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Alderman DA (1984). Review of cellulose ethers in hydrophilic matrices for oral controlled-release formulations, Int. J. Pharm., 5: 1-9. (Pubitemid 15105124)
2. CDER (1997). US Department of Health and Human Services, Food And Drug Administration, , Guidance for Industry: Dissolution Testing of Immediate Release Solid Dosage Forms. Available: www.fda.gov/.../Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf. Accessed 12 june, 2009.
3. CPMP (1999). EMEA Committee for Proprietary Products, London, UK., Note For Guidance On Quality Of Modified Release Products: A. Oral Dosage Forms. Available: www.ema.europa.eu/pdfs/human/qwp/060496en.pdf. Accessed at 12 june, 2009. Dhikav V, Sindhu S and Anand KS (2002).
4. Dhikav V, Sindhu S and Anand KS (2002). Newer nonsteroidal anti-inflammatory drugs: A review of their therapeutic potential and adverse drug reactions J. Indian Acad. Clin. Med., 3: 332-338.
5. Diclofenac potassium (2009). Available at:http://www. drugs.com/pro/diclofenac-potassium.html. Accessed at 16 June, 2009.
6. FDA (1995). Guideline for Industry, Immediate release solid oral dosage forms scale-up post approval changes (SUPAC) In vitro dissolution testing, US Department of Health and Human Services, Food and Drug Administration. Available: www.fda.gov/.../Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm070246.pdf Accessed 12 june, 2009.
7. Ford JL, Rubinstein MH, McCaul F, Hogan JE and Edgar PJ (1987). Importance of drug type, tablet shape, and added diluents on release of drug kinetics from HPMC tablets, Int. J. Pharm., 40: 223-234. (Pubitemid 18025827)
8. Ford JL, Rubenstein MH and Hogan JE (1985). Formulation of sustained release promethazine hydrochloride tablets using hydroxypropylmethyl cellulose matrices. Int. J. Pharm., 24: 327-338. (Pubitemid 15062540)
9. Higuchi T (1963). Mechanism of Rate of Sustained- Action Medication. Theoretical Analysis of Rate of Solid Drugs Dispersed In Matrices. J. Pharm. Sci., 52: 1145-1149.
10. Khan GM and Zhu JB (2001). Evaluation of Ethocel Premium ethyl cellulose derivatives with different molecular weighs as controlled release matrix forming functional polymers for Ibuprofen. The Sciences. 1: 361-367.
11. Khan GM and Median VM (2007). Drug release kinetic from tablet matrices based upon ethylcellulose etherderivatives: A comparison between different formulations. Drug Develop. Industry. Pharm., 33: 627-639. (Pubitemid 47035889)
12. Mitchell K, Ford JL, Armstrong DJ, Elliot PNC, Hogan JE and Rostron C (1993). The influence of substitution type on the performance of methyl cellulose and hydroxy propyl methyl cellulose in gels and matrices. Int. J. Pharm., 100: 143-154. (Pubitemid 23316326)
13. Ranga-Rao KV and Devi KP (1988). Swelling controlled release systems: Recent developments and applications. Int. J. Pharm., 48: 1-16.
14. Ritger RL and Peppas NS (1987). A simple equation for disposition of solute release ll: Fickian and anomalous release from swellable devices. J. Control Release, 5: 37-42.
15. Vert M, Li S and Garreau H (1991). More About the Degradation of LA/GA-derived Matrices in Aqueous Media. J. Control. Release, 16: 15-26.
16. Vijayakumar, Sathali and Arun (2010). Formulation and Evaluation of Diclofanac Potassium Ethosomes. Int. J. Pharm Pharm Sci, 2: 82-86.
17. Xu GJ and Sunada H (1995). Influence of formulation changes on drug release kinetics from hydroxypropyl methylcellulose matrix tablets. Chem. Pharm. Bull., 43: 483-487.